DAC vs No DAC: Why Safety Profiles May Differ The biggest safety distinction within the CJC-1295 category is duration of exposure
Short-term antiemetic use may be considered for persistent nausea, but metoclopramide should be used for a maximum of 5 days due to risk of side effects, and domperidone requires cardiac risk assessment
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
(c) On axial T2-WI, the tumor has a high signal intensity
Appetite signaling returns to baseline, and weight regulation depends on the lifestyle, nutrition, and metabolic infrastructure built during the active phase
